Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Urinary Catheters

October 19, 2017 updated by: Region Skane

Evaluation of a Novel Medical Device to Facilitate Gel Instillation During Change of Long-term Indwelling Urinary Catheters - a Randomized Controlled Study

A randomized, open label, controlled, parallel group study to investigate difference between regional standard procedure and a novel modified procedure (using an additional novel device to facilitate gel installation) for changing long-term indwelling urinary catheters.

Study Overview

Detailed Description

This is a randomized, open label, controlled, parallel group study, which comprises one visit that includes: assessment for eligibility, randomization to one of two treatment alternatives, followed by the actual intervention and evaluation of outcomes.

The interventions are either change of catheter according to the regional standard procedure (the comparator group) or change of catheter with the additional use of the novel device to facilitate gel instillation and a slightly modified procedure (the experimental group).

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Lund, Sweden, 22185
        • Skåne University Hospital - Urology clinic - Homecare unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • The patient has an indwelling catheter and a primary diagnosis that justify continued catheter use
  • The patient provides informed consent prior to any study specific procedures
  • The patient is considered to benefit from participation in the clinical study

Exclusion Criteria:

  • The patient do not consent to participate in the study
  • Trauma to urethra or bladder
  • Infection to urethra or bladder
  • Other diagnosis that contraindicates participation in the clinical study as judged by the responsible physician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Novel gel installation device procedure

Catheter change with novel device.

Each subject will undergo catheter change with novel gel instillation device procedure

Catheter change with novel device Each subject will undergo catheter change with novel gel instillation device
Active Comparator: Standard procedure

Catheter change with standard procedure.

Each subject will undergo catheter change with standard procedure

Catheter change with standard procedure Each subject will undergo catheter change with standard procedure

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Treatment duration (min)
Time Frame: During procedure
Treatment duration for procedure
During procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient's perceived pain (NRS scale)
Time Frame: During intervention
Patient's perceived pain estimated by patient using a numerical rating scale (NRS-scale)
During intervention
Number of gel syringes used
Time Frame: During intervention
Number of pre-filled gel syringes used during the procedure
During intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]
Time Frame: During intervention
Incidence of Treatment-Emergent Adverse Events found during procedure
During intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Ulf Malmqvist, PhD, Clinical Studies Sweden - Forum South

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2016

Primary Completion (Actual)

May 26, 2017

Study Completion (Actual)

May 26, 2017

Study Registration Dates

First Submitted

September 18, 2017

First Submitted That Met QC Criteria

September 18, 2017

First Posted (Actual)

September 20, 2017

Study Record Updates

Last Update Posted (Actual)

October 20, 2017

Last Update Submitted That Met QC Criteria

October 19, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Anesthesia, Local

Clinical Trials on Novel gel installation device procedure

3
Subscribe